- Home
- CCBG vs BIOA Comparison
CCBG vs BIOA Comparison
Compare CCBG & BIOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CCBG | BIOA |
|---|---|---|
| Founded | 1895 | 2015 |
| Country | United States | United States |
| Employees | N/A | 62 |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 729.7M | 681.9M |
| IPO Year | 1994 | N/A |
Fundamental Metrics
Financial Performance| Metric | CCBG | BIOA |
|---|---|---|
| Price | $47.12 | $18.04 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 6 |
| Target Price | $50.00 | ★ $51.50 |
| AVG Volume (30 Days) | 58.4K | ★ 375.7K |
| Earning Date | 04-20-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.34% | N/A |
| EPS Growth | ★ 15.38 | N/A |
| EPS | ★ 0.92 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $6.25 | $720.93 |
| Revenue Next Year | $3.17 | N/A |
| P/E Ratio | $50.39 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $36.21 | $4.07 |
| 52 Week High | $48.78 | $24.00 |
Technical Indicators
Market Signals| Indicator | CCBG | BIOA |
|---|---|---|
| Relative Strength Index (RSI) | 60.51 | 56.60 |
| Support Level | $43.60 | $15.49 |
| Resistance Level | $47.14 | $18.26 |
| Average True Range (ATR) | 1.05 | 1.03 |
| MACD | 0.15 | 0.09 |
| Stochastic Oscillator | 94.67 | 93.55 |
Price Performance
Historical ComparisonAbout CCBG Capital City Bank Group
Capital City Bank Group Inc is a United States-based group engaged in Banking services, Trust and asset management services, and Brokerage services. The company operates in one segment with two principal services: Banking Services and Wealth Management Services. It offers retail and commercial banking business in the form of traditional deposit and credit services, asset management, trust, mortgage banking, merchant services, bank cards, data processing, and securities brokerage services, among others, through its banking offices in Florida, Georgia, and Alabama.
About BIOA BioAge Labs Inc.
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging. The company's technology platform and differentiated human datasets enable the identification of targets based on insights into molecular changes that drive aging. The Company operates and manages its business as one reportable and operating segment, which is the business of extending healthy human life by targeting molecular causes of aging.